Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitex and Reduced Premenstrual Syndrome Symptom

Doses used in studies
  • mg/day: 20 (median 20, IQR 2020) 1 study
Safety in these studies
2 of 2 papers
Back to top